logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Discovery Labs Surges as FDA Agrees to Updated Surfaxin Specifications

By  +Follow October 4, 2013 2:07AM
Share:
Tickers Mentioned:

Shares of Discovery Laboratories, Inc. (DSCO) leapt forward immediately in Friday trading after the U.S. Food and Drug Administration agreed to updated product specifications for Surfaxin® Intratracheal Suspension, the company’s approved drug for the prevention of respiratory distress syndrome, or RDS, in premature infants at high risk for RDS. Surfaxin is the first synthetic, peptide-containing surfactant approved by the FDA and the only alternative to animal-derived surfactants. 

A surfactants is a liquid that coats the inside of the lungs and helps to keep them open.  Premature infants are not able to produce enough surfactant, resulting in lungs collapsing and the infant having difficulty breathing.

Other surfactants on the market are Survanta (beractant), Infasurf (calfactant) and Cornerstone Therapeutics’ (CRTX) Curosurf (poractant alpha), but, as mentioned, these drugs are derived from animals. Curosurf sales in the second quarter were $11.3 million, its best quarter on record. Italy’s Chiesi Farmaceutici, which already owns 58 percent of Cornerstone, agreed in September to pay $115 million for the remaining stake in the company that it didn’t already own to take it private.

In March 2012, the FDA approved Surfaxin for RDS and the drug was expected to be launched in the fourth quarter of 2013, but Discovery determined through a routine review that one of its analytical chemistry methods used to assess the performance of Surfaxin required improvement, delaying the launch by two quarters. 

Then in April, Warrington, Pennsylvania-based Discovery disclosed that the FDA requested more information on product specifications of Surfaxin, further delaying the launch and sending shares of DSCO plunging about 40 percent to lows of $1.50.

Discovery has now met the demands of the FDA that have plagued product launch. The company has initiated manufacturing of Surfaxin for its planned commercial introduction in the fourth quarter of 2013.

"We are pleased that the FDA has agreed with our updated product specifications and are appreciative of the process that has lead to this decision," said John G. Cooper, chief executive of Discovery in a statement today. "Surfaxin represents the first milestone in our goal of transforming the treatment of RDS and is an important medical advancement for the neonatology community and parents of preterm infants who will soon have an effective alternative to animal-derived surfactants for the prevention of RDS."

Shares of DSCO drove north of $3.00 shortly after Friday’s opening from Thursday’s closing price of $1.97, but have cooled off to $2.75 1-1/2 hours into the trading session for gains of around 40 percent.  Through Thursday’s close, shares were down about 6 percent in 2013, but have reversed the losses with today’s climb

Results for dsco
Wolfgang Mueller
24 Apr 14 07:08:19
You miss 100% of the shots you don't take.-Gretzky $ERBB $IDTA $ONCS $INO $DSCO $SPLI $MINE $nwbo
BradTrader
24 Apr 14 06:56:06
$DSCO Karyopharm Initiates Phase 2 Study of Selinexor in Patients With Advanced ... http://t.co/AcvUcQXcJ4
Fox Galvanes
24 Apr 14 05:59:11
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/xGfO2dwZfw
BradTrader
24 Apr 14 05:38:06
$DSCO GENOCEA Co-Founder Receives TIME Magazine's TIME 100 Honor http://t.co/gRUNQrCLvh
Major Brown
24 Apr 14 04:16:32
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in http://t.co/c1NDs8BRfN
$Stocknewsalerts
24 Apr 14 04:13:40
$DSCO DISH Announces Conference Call for First Quarter 2014 Financial Results
Jaydan Kyler
24 Apr 14 03:36:57
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/Sj9Edt7vn0
Louie O'Malley
24 Apr 14 02:57:34
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/zdW5MR4orU
BradTrader
23 Apr 14 18:04:04
$DSCO CORRECTING AND REPLACING:/ ContraVir Strengthens Its Board of Directors ... http://t.co/Lz0DycJ75i
Wolfgang Mueller
23 Apr 14 16:03:02
@jimcramer You have a lot of haters BUT I defend you. You make the complex simple and that's how I know you get it. $ONCS $INO $ERBB $DSCO
Brenden Black
23 Apr 14 15:14:30
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/wdUKvERGDm
Yahaira Landry
23 Apr 14 12:51:15
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in http://t.co/7qudJLjyHh
Jayna Champagne
23 Apr 14 11:16:03
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/xKThv5oCnB
Lars Kingston
23 Apr 14 10:05:51
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in http://t.co/OJMXLcxAv9
BradTrader
23 Apr 14 08:36:06
$DSCO VistaGen Receives Notice of Allowance for US Patent Expanding Stem Cell ... http://t.co/xeJ9yTGj7D
WallStreet Pennies
23 Apr 14 01:53:00
Dollar$OnPennies: $DSCO Gallery View http://t.co/xQIqS8u8W3
Jet Life PennyStock$
23 Apr 14 01:49:05
Dollar$OnPennies: $DSCO Gallery View http://t.co/PbN9mdRSsk
BradTrader
22 Apr 14 20:17:11
$DSCO Harlan Laboratories Announces Invenium Pharmacology as Agent for Southeast ... http://t.co/bfsYuTMZXW
Vishal Toora
22 Apr 14 20:08:22
April 23rd watchlist: $AVEO $ADAT $AMSC $ARQL $CAK $DSCO $DVAX $IDN $IMRS $MCZ #stocks
BradTrader
22 Apr 14 16:35:13
$DSCO Myriad Genetics to Announce Financial Results for the Third Quarter of Fiscal ... http://t.co/G6gJCF32zY
Dmitri Magnuson
22 Apr 14 16:18:11
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/M28DwUQsWk
Enoch Cohen
22 Apr 14 13:50:43
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in http://t.co/VJGmIyVFGC
Investor
22 Apr 14 11:49:58
$DSCO holding it
Large Void Bot
22 Apr 14 07:10:08
Daily Reversal (10:10): $DSCO Last: 1.97; pHigh: 1.97; rVol: 0.134; pClose: 1.92; LOD: 1.96; Perf: 2.6%
Wolfgang Mueller
22 Apr 14 07:05:14
@timothysykes $twtr was a good call off the lower bb and low rsi of 30. Keep making money. Thoughts on $dsco please. Peace.
Patty Porter
22 Apr 14 05:57:07
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in http://t.co/X9Mb3RrDfH
BradTrader
22 Apr 14 02:27:43
$DSCO Karyopharm Announces a Phase 1 Trial of Selinexor (KPT-330) in Pediatric ... http://t.co/6haxcG2McG
Lars Anders
21 Apr 14 18:31:56
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in http://t.co/Nfrg7g9Qpl
Crew Daily
21 Apr 14 04:23:56
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/Xg8v5sharV
G.T..
21 Apr 14 03:47:01
RT @Insaencula: $LJPC $ROSG $SYN $SGYP $AVNR $DSCO $NBY $IDRA $ATHX $ZIOP
Johann Garcia
21 Apr 14 02:36:13
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/0Dpjk914Vb
Jet Life PennyStock$
21 Apr 14 02:34:01
Dollar$OnPennies: $DSCO Gallery View http://t.co/uSQfHyt5PP
WallStreet Pennies
21 Apr 14 01:56:40
Dollar$OnPennies: $DSCO Gallery View http://t.co/Unyg51Yge7
Gary Rosovsky
20 Apr 14 10:48:35
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/biaQ9LdiXt
Lars Meath
20 Apr 14 09:56:27
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/uw4AqCtEC5
Aide Lemmon
20 Apr 14 08:37:27
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/m7RYtHD2CZ
Leighton Kingston
20 Apr 14 07:18:10
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/W6BYHRGaGO
Jet Life PennyStock$
20 Apr 14 01:32:37
Dollar$OnPennies: $DSCO Gallery View http://t.co/OMHCgicPFT
Porphyrius
19 Apr 14 21:03:47
$LJPC $ROSG $SYN $SGYP $AVNR $DSCO $NBY $IDRA $ATHX $ZIOP
BradTrader
19 Apr 14 18:52:05
$DSCO Chromatography Instrumentation Market Worth $10008.3 Million by 2018 ... http://t.co/N8XfEQq6BJ
Genie Pike
19 Apr 14 15:13:08
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/oIVkbQGNti
chartguy89
19 Apr 14 14:40:25
DSCO 1.90 Stock Charts $DSCO Discovery Laboratories Inc. (NASDAQ) DSCO Stock Chart - 1 Month http://bigcharts. http://t.co/h2wSGik0WI
Darryl Kendal
19 Apr 14 11:38:18
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/TsgjeMS8An
Rudolf Shavera
19 Apr 14 05:17:20
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/CAJ1zeLq5t
WallStreet Pennies
19 Apr 14 01:47:41
Dollar$OnPennies: $DSCO Gallery View http://t.co/6gr84YH3KV
Ansel Galvan
19 Apr 14 01:41:00
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/gtGQJOvu2n
Basil Gall
18 Apr 14 16:28:54
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in Dire http://t.co/wfIEaFdVbF
Stock_Tracker
18 Apr 14 08:40:58
Discovery Laboratories (DSCO) 1.90 $DSCO What Falling Estimates & Price Mean for Discovery Laboratories (DSCO) http://t.co/QuuyJqPmAn
Lilly Bynum
18 Apr 14 05:14:29
$DSCO DISCOVERY LABORATORIES INC /DE/ Files SEC form 8-K, Change in http://t.co/dkmzsI8hlS
$Stocknewsalerts
17 Apr 14 16:15:30
$DSCO New SEC Document(s) for DISH Network Corporation
				
				
By  +Follow October 4, 2013 2:07AM
Share:

Editor's Picks

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.